| HOME >> MEDICINE >> TECHNOLOGY |
Table 27: The US 15-Year Perspective for Growth Factors by
Type - Percentage Breakdown of Value Sales for Blood Growth
Factors (Erythropoietins, Colony Stimulating Factors,
Interferons and Interleukins) and Tissue Growth Factors
Markets for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) III-4
2. JAPAN III-5A.Market Analysis III-5Erythropoietin Market III-5Leading EPO Drugs in Japan III-5Market Scenario for Biotech Products III-5Biotech Market Backed by Public Assistance III-5B.Market Analytics III-6Table 28: Japanese Recent Past, Current & Future Analysisfor Growth Factors by Type - Blood Growth Factors(Erythropoietins, Colony Stimulating Factors, Interferonsand Interleukins) and Tissue Growth Factors MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2009 through 2017 (includes correspondingGraph/Chart) III-6
Table 29: Japanese Historic Review for Growth Factors by
Type - Blood Growth Factors (Erythropoietins, Colony
Stimulating Factors, Interferons and Interleukins) and
Tissue Growth Factors Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) III-7
Table 30: Japanese 15-Year Perspective for Growth Factors byType - Percentage Breakdown of Value Sales for Blood GrowthFactors (Erythropoietins, Colony Stimulating Factors,Interferons and Interleukins) and Tissue Growth FactorsMarkets for Years 2003, 2011 & 2017(includes correspondingGraph/Chart) III-8
3. EUROPE III-9
A.Market Analysis III-9
Eryth
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |